Incyte (INCY) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mail
Get Alerts INCY Hot Sheet
Price: $115.71 -1.04%
EPS Growth %: -256.2%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -256.2%
Financial Fact:
Research and development: 143.18M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Incyte (NASDAQ: INCY) reported Q1 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $382 million versus the consensus estimate of $390.05 million.
For earnings history and earnings-related data on Incyte (INCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Assumes Incyte (INCY) at Equalweight
- Caldwell sells IQTalent subsidiary to WinMil for C$4.7M
- Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
